Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Diseases, Inborn × Circulating Tumor DNA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Glioblastoma 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Melanoma 1 Locally Advanced Rectal Carcinoma 1 Hypoxia 1 Gliosarcoma 1 Glioma 1 Genetic Diseases, Inborn 1 Esophageal Neoplasms 1 Circulating Tumor DNA 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Melphalan 3 Magnetic Resonance Spectroscopy 2 Blood Specimen Collection 2 thymoglobulin 1 sargramostim 1 romidepsin 1 montanide ISA 51 1 keyhole-limpet hemocyanin 1 ixazomib 1 detox adjuvant 1 Waiting Lists 1 Ursodeoxycholic Acid 1 Transplantation 1 Thalidomide 1 Tablets 1 Surveys and Questionnaires 1 Streptozocin 1 Specimen Handling 1 Restraint, Physical 1 Radiosurgery 1 Radiation 1 Mercaptopurine 1 Leucovorin 1 Ketoconazole 1 Interleukin-2 1 Fulvestrant 1 Floxuridine 1 FANG vaccine 1 Docetaxel 1 Diagnostic Tests, Routine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03115138 2020-07-15

Bi-GLAM

Centre Hospitalier Universitaire, Amiens

Phase NA Terminated

Glioblastoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡